178 related articles for article (PubMed ID: 32013885)
1. Metformin improves lipid metabolism and reverses the Warburg effect in a canine model of chronic atrial fibrillation.
Liu Y; Bai F; Liu N; Zhang B; Qin F; Tu T; Li B; Li J; Ma Y; Ouyang F; Liu Q
BMC Cardiovasc Disord; 2020 Feb; 20(1):50. PubMed ID: 32013885
[TBL] [Abstract][Full Text] [Related]
2. Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway.
Bai F; Liu Y; Tu T; Li B; Xiao Y; Ma Y; Qin F; Xie J; Zhou S; Liu Q
Lipids Health Dis; 2019 May; 18(1):109. PubMed ID: 31077199
[TBL] [Abstract][Full Text] [Related]
3. Metformin therapy confers cardioprotection against the remodeling of gap junction in tachycardia-induced atrial fibrillation dog model.
Li J; Li B; Bai F; Ma Y; Liu N; Liu Y; Wang Y; Liu Q
Life Sci; 2020 Aug; 254():117759. PubMed ID: 32389830
[TBL] [Abstract][Full Text] [Related]
4. Activation of AMP-Activated Protein Kinases Prevents Atrial Fibrillation.
Ozcan C; Dixit G; Li Z
J Cardiovasc Transl Res; 2021 Jun; 14(3):492-502. PubMed ID: 32844365
[TBL] [Abstract][Full Text] [Related]
5. Linagliptin prevents atrial electrical and structural remodeling in a canine model of atrial fibrillation.
Igarashi T; Niwano S; Niwano H; Yoshizawa T; Nakamura H; Fukaya H; Fujiishi T; Ishizue N; Satoh A; Kishihara J; Murakami M; Ako J
Heart Vessels; 2018 Oct; 33(10):1258-1265. PubMed ID: 29721673
[TBL] [Abstract][Full Text] [Related]
6. Regulating the Warburg effect on metabolic stress and myocardial fibrosis remodeling and atrial intracardiac waveform activity induced by atrial fibrillation.
Hu HJ; Zhang C; Tang ZH; Qu SL; Jiang ZS
Biochem Biophys Res Commun; 2019 Aug; 516(3):653-660. PubMed ID: 31242971
[TBL] [Abstract][Full Text] [Related]
7. Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability.
Li B; Po SS; Zhang B; Bai F; Li J; Qin F; Liu N; Sun C; Xiao Y; Tu T; Zhou S; Liu Q
J Cell Mol Med; 2020 Jul; 24(14):7751-7766. PubMed ID: 32441464
[TBL] [Abstract][Full Text] [Related]
8. Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation.
Li LY; Lou Q; Liu GZ; Lv JC; Yun FX; Li TK; Yang W; Zhao HY; Zhang L; Bai N; Zhan CC; Yu J; Zang YX; Li WM
Eur J Pharmacol; 2020 Aug; 881():173120. PubMed ID: 32325147
[TBL] [Abstract][Full Text] [Related]
9. Effects of Cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs.
Li Y; Li W; Yang B; Han W; Dong D; Xue J; Li B; Yang S; Sheng L
J Electrocardiol; 2007 Jan; 40(1):100.e1-6. PubMed ID: 17067622
[TBL] [Abstract][Full Text] [Related]
10. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation.
Morillo CA; Klein GJ; Jones DL; Guiraudon CM
Circulation; 1995 Mar; 91(5):1588-95. PubMed ID: 7867201
[TBL] [Abstract][Full Text] [Related]
11. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs.
Li Y; Li WM; Gong YT; Li BX; Liu W; Han W; Dong D; Sheng L; Xue JY; Zhang L; Chu S; Yang BF
Basic Res Cardiol; 2007 May; 102(3):245-56. PubMed ID: 17268887
[TBL] [Abstract][Full Text] [Related]
12. β3-adrenoceptor mediates metabolic protein remodeling in a rabbit model of tachypacing-induced atrial fibrillation.
Liu Y; Geng J; Liu Y; Li Y; Shen J; Xiao X; Sheng L; Yang B; Cheng C; Li W
Cell Physiol Biochem; 2013; 32(6):1631-42. PubMed ID: 24335437
[TBL] [Abstract][Full Text] [Related]
13. Liraglutide suppresses atrial electrophysiological changes.
Nakamura H; Niwano S; Niwano H; Fukaya H; Murakami M; Kishihara J; Satoh A; Yoshizawa T; Ishizue N; Igarashi T; Fujiishi T; Ako J
Heart Vessels; 2019 Aug; 34(8):1389-1393. PubMed ID: 30762094
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway.
Liu GZ; Hou TT; Yuan Y; Hang PZ; Zhao JJ; Sun L; Zhao GQ; Zhao J; Dong JM; Wang XB; Shi H; Liu YW; Zhou JH; Dong ZX; Liu Y; Zhan CC; Li Y; Li WM
Br J Pharmacol; 2016 Mar; 173(6):1095-109. PubMed ID: 26787506
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal study of electrical, functional and structural remodelling in an equine model of atrial fibrillation.
Hesselkilde EZ; Carstensen H; Flethøj M; Fenner M; Kruse DD; Sattler SM; Tfelt-Hansen J; Pehrson S; Braunstein TH; Carlson J; Platonov PG; Jespersen T; Buhl R
BMC Cardiovasc Disord; 2019 Oct; 19(1):228. PubMed ID: 31638896
[TBL] [Abstract][Full Text] [Related]
16. Atrial Fibrillation Activates AMP-Dependent Protein Kinase and its Regulation of Cellular Calcium Handling: Potential Role in Metabolic Adaptation and Prevention of Progression.
Harada M; Tadevosyan A; Qi X; Xiao J; Liu T; Voigt N; Karck M; Kamler M; Kodama I; Murohara T; Dobrev D; Nattel S
J Am Coll Cardiol; 2015 Jul; 66(1):47-58. PubMed ID: 26139058
[TBL] [Abstract][Full Text] [Related]
17. Antiremodeling Effect of Xanthine Oxidase Inhibition in a Canine Model of Atrial Fibrillation.
Yoshizawa T; Niwano S; Niwano H; Tamaki H; Nakamura H; Igarashi T; Oikawa J; Satoh A; Kishihara J; Murakami M; Fukaya H; Ako J
Int Heart J; 2018 Sep; 59(5):1077-1085. PubMed ID: 30158379
[TBL] [Abstract][Full Text] [Related]
18. Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats.
Shao Q; Meng L; Lee S; Tse G; Gong M; Zhang Z; Zhao J; Zhao Y; Li G; Liu T
Cardiovasc Diabetol; 2019 Nov; 18(1):165. PubMed ID: 31779619
[TBL] [Abstract][Full Text] [Related]
19. Atrial overexpression of angiotensin-converting enzyme 2 improves the canine rapid atrial pacing-induced structural and electrical remodeling. Fan, ACE2 improves atrial substrate remodeling.
Fan J; Zou L; Cui K; Woo K; Du H; Chen S; Ling Z; Zhang Q; Zhang B; Lan X; Su L; Zrenner B; Yin Y
Basic Res Cardiol; 2015; 110(4):45. PubMed ID: 26143546
[TBL] [Abstract][Full Text] [Related]
20. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction.
Sakabe M; Fujiki A; Sakamoto T; Nakatani Y; Mizumaki K; Inoue H
J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1130-5. PubMed ID: 22587612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
